Endeavor

Many Breast Cancer Patients Don’t Need Radiation After Surgery

Trial results show radiation to chest wall made no difference in survival in early stage patients

Combination Therapy Before Surgery Shows Promise for Aggressive Skin Cancer

Moffitt-led study explores how pairing lenvatinib and pembrolizumab strengthens immune response against Merkel cell carcinoma

Experimental Injectable Therapy Offers Nonsurgical Treatment of Common Skin Cancer

Phase 2 study led by Moffitt researchers finds VP-315 triggers strong local and systemic immune response against basal cell carcinoma

TIL Therapy Research Expanded to Bladder Cancer

Almost half of patients enrolled in a Moffitt trial responded to the cellular immunotherapy

On Course for a Full Life

After beating oropharynx cancer, Eric Bilow shows there’s no challenge he won’t take on

Moffitt’s McKinley Outpatient Center Celebrates 10th Anniversary

Even a decade after its opening, the campus continues to evolve

Can Hybrid Immunotherapy Improve Solid Tumor Treatment?

Moffitt researchers test CAR-TIL cells combining tumor navigation and targeted attack

Honoring a Legacy of Compassion at Moffitt

The Patti K. Halula Legacy Award celebrates team members who lead with heart, humility and humanity

Flipping the Switch: New Moffitt Research Offers 2 Ways To Outsmart Drug Resistance in Lung Cancer

Two companion studies reveal new ways to prevent and defeat drug resistance in KRAS-driven lung cancer